These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
713 related articles for article (PubMed ID: 7479819)
1. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Aiello LP; Pierce EA; Foley ED; Takagi H; Chen H; Riddle L; Ferrara N; King GL; Smith LE Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10457-61. PubMed ID: 7479819 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization. Suzuma K; Takagi H; Otani A; Suzuma I; Honda Y Microvasc Res; 1998 Nov; 56(3):183-91. PubMed ID: 9828156 [TBL] [Abstract][Full Text] [Related]
3. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization. Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody. Zhu Z; Lu D; Kotanides H; Santiago A; Jimenez X; Simcox T; Hicklin DJ; Bohlen P; Witte L Cancer Lett; 1999 Mar; 136(2):203-13. PubMed ID: 10355750 [TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Takagi H; King GL; Aiello LP Diabetes; 1996 Aug; 45(8):1016-23. PubMed ID: 8690146 [TBL] [Abstract][Full Text] [Related]
6. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor. Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724 [TBL] [Abstract][Full Text] [Related]
8. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ. Takayama K; Ueno H; Nakanishi Y; Sakamoto T; Inoue K; Shimizu K; Oohashi H; Hara N Cancer Res; 2000 Apr; 60(8):2169-77. PubMed ID: 10786681 [TBL] [Abstract][Full Text] [Related]
9. Blockade of in vivo VEGF-mediated angiogenesis by antisense gene therapy: role of Flk-1 and Flt-1 receptors. Marchand GS; Noiseux N; Tanguay JF; Sirois MG Am J Physiol Heart Circ Physiol; 2002 Jan; 282(1):H194-204. PubMed ID: 11748063 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Hammes HP; Lin J; Bretzel RG; Brownlee M; Breier G Diabetes; 1998 Mar; 47(3):401-6. PubMed ID: 9519746 [TBL] [Abstract][Full Text] [Related]
12. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma. Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546 [TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Thieme H; Aiello LP; Takagi H; Ferrara N; King GL Diabetes; 1995 Jan; 44(1):98-103. PubMed ID: 7529203 [TBL] [Abstract][Full Text] [Related]
14. Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Suzuma I; Hata Y; Clermont A; Pokras F; Rook SL; Suzuma K; Feener EP; Aiello LP Diabetes; 2001 Feb; 50(2):444-54. PubMed ID: 11272159 [TBL] [Abstract][Full Text] [Related]
15. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy. McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393 [TBL] [Abstract][Full Text] [Related]
16. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Aiello LP; Northrup JM; Keyt BA; Takagi H; Iwamoto MA Arch Ophthalmol; 1995 Dec; 113(12):1538-44. PubMed ID: 7487623 [TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor and its receptor, KDR, following retinal ischemia-reperfusion injury in the rat. Ogata N; Yamanaka R; Yamamoto C; Miyashiro M; Kimoto T; Takahashi K; Maruyama K; Uyama M Curr Eye Res; 1998 Nov; 17(11):1087-96. PubMed ID: 9846628 [TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212 [TBL] [Abstract][Full Text] [Related]
19. Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia. Ozaki NK; Beharry KD; Nishihara KC; Akmal Y; Ang JG; Sheikh R; Modanlou HD Invest Ophthalmol Vis Sci; 2002 May; 43(5):1546-57. PubMed ID: 11980873 [TBL] [Abstract][Full Text] [Related]
20. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. Park JE; Chen HH; Winer J; Houck KA; Ferrara N J Biol Chem; 1994 Oct; 269(41):25646-54. PubMed ID: 7929268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]